Six of the patients, of whom four had non-renal SLE, had follow-up of at least 24 weeks. Of those, five showed dramatic ...

A retrospective study presented at the recent American Society of Clinical Oncology (ASCO) meeting suggested that patients ...

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers ...

Scientists with the Fralin Biomedical Research Institute at VTC have created an engineered model of the supportive tissue ...

KITE-363, a dual-targeting CAR T-cell therapy, shows a strong safety profile and high responses in patients who have highly ...

Adding IL-12 to mRNA vaccines can lead to longer lasting protective effect and a potential approach for reducing the risk of ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

Cabaletta announced promising results of its lead T-cell therapy candidate targeting autoimmune diseases. Eagles owner ...

Swiss-led study using single-cell RNA sequencing finds early immune activation in fibroblasts may be a key trigger in the ...

Celiac disease frustratingly restrictive, the only real medical intervention for sufferers being to avoid gluten altogether.